Dr. Tory Prestera and Dr. Howard Guan share key differences between dry and wet macular degeneration, including common symptoms, causes, and treatment options. Dry macular degeneration is the more ...
MedPage Today on MSN
VEGF Inhibitor Implant Preserves Visual Acuity, Retinal Anatomy in Wet AMD
Good baseline visual acuity retained in three-fourths of patients at 36 weeks with OTX-TKI ...
Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with advanced dry macular degeneration. The hair-thin patch replaces damaged retinal ...
SOL-X long-term extension trial in wet AMD enrolled the first subject in April 2026 who had successfully completed the two-year SOL-1 trial ...
Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.
The Healthy @Reader's Digest on MSN
What I wish I’d known about cataract surgery: A doctor details what patients should know about a common procedure
An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of miracle and wonder." The post “What I Wish I’d Known About Cataract ...
Enrollment underway in SOL-X long-term extension trial in wet AMD for subjects completing two-year follow-up in SOL-1 or SOL-RAnnounced positive ...
Good morning, and welcome to Ocugen First Quarter 2026 Financial Results and Business Update. [Operator Instructions] I will now turn the call over to Tiffany Hamilton, Ocugen's Head of Corporate ...
Morning Overview on MSN
Artificial retina aims to restore sight and add a new vision channel
Roughly 200 million people worldwide live with age-related macular degeneration, a condition that erodes central vision and, in its advanced dry form, has no approved treatment that can reverse the ...
Headlines warning about “Ozempic blindness” may be frightening to the millions of people taking a GLP-1 drug to treat Type 2 diabetes or for weight loss. It's not an official diagnosis, but an ...
A tiny wireless implant is giving new hope to people blinded by advanced age-related macular degeneration. In a major international clinical trial, more than 80% of participants regained meaningful ...
A new federally funded research effort in Rochester is aiming to tackle one of the biggest gaps in treating age-related macular degeneration — stopping vision loss before it starts. Researchers at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results